230 related articles for article (PubMed ID: 21692132)
21. Germline mutations and genotype-phenotype associations in head and neck paraganglioma patients with negative family history in China.
Zhu WD; Wang ZY; Chai YC; Wang XW; Chen DY; Wu H
Eur J Med Genet; 2015 Sep; 58(9):433-8. PubMed ID: 26096992
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
24. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
26. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
28. The genetics of paragangliomas: a review.
Martin TP; Irving RM; Maher ER
Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
[TBL] [Abstract][Full Text] [Related]
30. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
31. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
32. Rare presentation of familial paraganglioma without evidence of mutation in the SDH, RET and VHL genes: towards further genetic heterogeneity.
Persu A; Amyere M; Gutierrez-Roelens I; Rustin P; Sempoux C; Lecouvet FE; Van Beers BE; Horsmans Y; De Plaen JF; MarcHamoir ; Vikkula M
J Hypertens; 2009 Jan; 27(1):76-82. PubMed ID: 19145771
[TBL] [Abstract][Full Text] [Related]
33. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
34. Familial paraganglioma syndromes.
Chetty R
J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
[TBL] [Abstract][Full Text] [Related]
35. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
36. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
37. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report.
Papaspyrou K; Rossmann H; Fottner C; Weber MM; Mann W; Lackner KJ; Helling K
Head Neck; 2008 Jul; 30(7):964-9. PubMed ID: 18213727
[TBL] [Abstract][Full Text] [Related]
38. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
[TBL] [Abstract][Full Text] [Related]
39. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract][Full Text] [Related]
40. No difference in phenotype of the main Dutch SDHD founder mutations.
van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
